Submitted by Anonymous (not verified) on 23 March 2026 - 12:10
Human medicines European public assessment report (EPAR): Waylivra, volanesorsen, Date of authorisation: 03/05/2019, Revision: 8, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Waylivra, volanesorsen, Date of authorisation: 03/05/2019, Revision: 8, Status: Authorised